Pricing Log in Create free account

Aardvark Therapeutics, Inc. (AARD) vs Promis Neurosciences (PMN)

Aardvark Therapeutics, Inc. and Promis Neurosciences are both Biotechnology companies. Aardvark Therapeutics, Inc. and Promis Neurosciences are of similar size ($84.5M and $78.0M). Across the 9 metrics below, Aardvark Therapeutics, Inc. leads on 6 and Promis Neurosciences on 3.

Valuation

Metric AARD PMN Biotechnology median
P/E n/m n/m 8.50
P/S n/m 33,868.44 9.71
P/B 1.10 1.51 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 11,382.03 9.21
Earnings yield (84.92%) (155.70%) (33.15%)
Free cash flow yield (84.17%) (56.51%) (25.50%)

Profitability

Metric AARD PMN Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (66.02%) (172.30%) (56.36%)
Return on assets (61.06%) (127.57%) (48.04%)
Return on invested capital (4,986.18%) 0.00% 0.00%

Growth

Metric AARD PMN Biotechnology median
Revenue growth (TTM) — 450.00% 6.02%
EPS growth (last fiscal year) 43.11% (922.18%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric AARD PMN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 12.63 7.85 4.72
Net debt to EBITDA 1.72 0.15 0.96

Dividend

Metric AARD PMN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric AARD PMN Biotechnology median
Market cap 84.47m 78.02m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack